InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 in China
Press release content from Business Wire. The AP news staff was not involved in its creation.
United States Hong Kong Jasmine Cui Chunhua Lu Innocare Pharma National Medical Products Administration
Source: apnews.com